Search Orphan Drug Designations and Approvals
-
| Generic Name: | autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 |
|---|---|
| Date Designated: | 08/21/2024 |
| Orphan Designation: | treatment of stiff person syndrome |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Kyverna Therapeutics, Inc 5980 Horton Street, Suite 200 Emeryville, California 94608 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







